LIVE
4.2M influencer listings 🏢50.5K sponsor listings 🌍67.6B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.7M Bluesky creators 🎙️1.2M podcast creators 🟣793.1K Twitch creators 🐘157.4K Mastodon creators 🥊100.3K Kick creators ▶️81.7K YouTube creators 𝕏74.6K X creators 📈61.4K Pinterest creators ✈️55.8K Telegram creators 🎵33.1K TikTok creators 🎮8.1K Discord creators 🎬4K Rumble creators 📈2.2K Substack creators 🧵1.6K Threads creators 4.2M influencer listings 🏢50.5K sponsor listings 🌍67.6B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.7M Bluesky creators 🎙️1.2M podcast creators 🟣793.1K Twitch creators 🐘157.4K Mastodon creators 🥊100.3K Kick creators ▶️81.7K YouTube creators 𝕏74.6K X creators 📈61.4K Pinterest creators ✈️55.8K Telegram creators 🎵33.1K TikTok creators 🎮8.1K Discord creators 🎬4K Rumble creators 📈2.2K Substack creators 🧵1.6K Threads creators
All Things Biosimilar

All Things Biosimilar

🔄 Data last refreshed 2 days ago
🤝

Make a deal with All Things Biosimilar

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Every booking is a normal escrow-protected deal.

Ratings
N/A
Episodes
4
Cadence
0.5 ep/wk
Latest episode
8 months ago
🎁 Free analysisfor All Things Biosimilar

💡 Facts

📤Posts about 0.5× per week.

👥 Audience demographics

Estimated

Modeled from this creator's niche, platform & region — a planning estimate, not connected analytics.

Gender split
Male 74% Female 26%
Age · peak 25-34
13-176%
18-2427%
25-3431%
35-4422%
45+14%
Top geographies
  • United States34%
  • India11%
  • United Kingdom8%
  • Brazil6%
  • Indonesia5%
Likely interests
EntertainmentLifestyleTrending

💚 Brand affinity

Estimated

Brands All Things Biosimilar's audience is most likely to respond to — from detected sponsorships in this niche.

Keeps Shopify Neuberger Explore NBSD Betterment Gymshark VanEck Nuveen DBMF Webull Charles Schwab Media

About

Stay on the pulse of the U.S. biosimilars industry with All Things Biosimilar. Hosted by Andrew Bourgoin, founder of Bourgoin Insights Group, this podcast is your source for timely insights into the dynamic biosimilar market. Each episode unpacks the latest developments, including in-depth analysis of the U.S. retina market, the competitive dynamics for ustekinumab and aflibercept biosimilars, and what to watch for in quarterly earnings. If you need to understand the forces driving the market today, this is the podcast for you. Subscribe to stay informed.

✉ Message All Things Biosimilar

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with All Things Biosimilar

Booking an event / appearance is a Pro feature. Upgrade to book All Things Biosimilar for an in-person or virtual appearance — payment held safely in escrow until the event is done.

See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from Podcast's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove